Aftab Dana (CIK 1959132) reported 20 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-19). Recent activity: Sell EXEL (30,578 shares), Buy EXEL (52,018 shares), Sell EXEL (47,918 shares), Sell EXEL (29,873 shares), Sell EXEL (26,485 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-19 | EXELIXIS, INC. (EXEL) | EVP, Research and Development | Sell | 30,578 | $1.6M |
| 2026-03-02 | EXELIXIS, INC. (EXEL) | EVP, Research and Development | Buy | 52,018 | $0 |
| 2026-02-26 | EXELIXIS, INC. (EXEL) | EVP, Research and Development | Sell | 47,918 | $2.1M |
| 2026-02-23 | EXELIXIS, INC. (EXEL) | EVP, Research and Development | Sell | 29,873 | $1.3M |
| 2026-02-18 | EXELIXIS, INC. (EXEL) | EVP, Research and Development | Sell | 26,485 | $1.2M |
| 2026-02-18 | EXELIXIS, INC. (EXEL) | EVP, Research and Development | Sell | 12,720 | $558,662 |
| 2026-01-16 | EXELIXIS, INC. (EXEL) | EVP, Research and Development | Buy | 119,578 | $0 |
| 2026-01-16 | EXELIXIS, INC. (EXEL) | EVP, Research and Development | Sell | 27,254 | $1.2M |
| 2025-11-24 | EXELIXIS, INC. (EXEL) | EVP, Research and Development | Sell | 24,000 | $0 |
| 2025-11-13 | EXELIXIS, INC. (EXEL) | EVP, Research and Development | Sell | 48,383 | $2.1M |
| 2025-10-10 | EXELIXIS, INC. (EXEL) | EVP, Research & Development | Buy | 50,673 | $0 |
| 2025-05-16 | EXELIXIS, INC. (EXEL) | CSO/EVP Disc & Trans Research | Sell | 30,693 | $1.4M |
| 2025-05-05 | EXELIXIS, INC. (EXEL) | CSO/EVP Disc & Trans Research | Sell | 1,508 | $58,812 |
| 2025-03-31 | EXELIXIS, INC. (EXEL) | CSO/EVP Disc & Trans Research | Buy | 132,819 | $0 |
| 2025-02-28 | EXELIXIS, INC. (EXEL) | CSO/EVP Disc & Trans Research | Buy | 49,209 | $0 |
| 2025-02-26 | EXELIXIS, INC. (EXEL) | CSO/EVP Disc & Trans Research | Sell | 26,987 | $991,772 |
| 2025-02-19 | EXELIXIS, INC. (EXEL) | CSO/EVP Disc & Trans Research | Sell | 16,053 | $561,855 |
| 2025-02-19 | EXELIXIS, INC. (EXEL) | CSO/EVP Disc & Trans Research | Sell | 12,695 | $444,325 |
| 2025-01-17 | EXELIXIS, INC. (EXEL) | CSO/EVP Disc & Trans Research | Buy | 104,106 | $0 |
| 2025-01-17 | EXELIXIS, INC. (EXEL) | CSO/EVP Disc & Trans Research | Sell | 22,570 | $841,184 |
Source: SEC Form 4 filings · as of 2026-05-19